Company intelligence / Profile preview

Lympha Press

Chadds Ford* / Glen Mills**, Pennsylvania, United Stateslymphapress.com ↗

Ownership: Private
Employees: ~111
Development stage: Commercial

Overview

Lympha Press’s pneumatic compression devices are clinically proven and widely used for at-home management of lymphedema, lipedema, chronic venous insufficiency, and related conditions. The products are supported by over twenty peer-reviewed publications and have demonstrated improved patient outcomes and quality of life in real-world use. No clinical trial pipeline as the company markets medical devices rather than drugs.

Therapeutic areas: CardiovascularDermatologyMetabolic Disorders
Modalities: DeviceNon-pharmacological therapyPneumatic compression therapy device
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

Optimal Plus

Commercial

Indications: Lymphedema, Lipedema, Chronic venous insufficiency

Partnerships

Mego Afek AC LTD. (manufacturer)

Beyond the preview

Go deeper on Lympha Press.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lympha Press.

Explore the full profile